Introduction: An international multicenter randomized trial comparing stand
ard pressure differential valves, Orbis Sigma valves and PS Medical Delta v
alves, for children with newly diagnosed hydrocephalus failed to show a dif
ference in the time to first shunt failure (power 80%). In order to avoid o
bserver bias, the primary end-point, shunt failure, was defined by detailed
clinical and radiological criteria. Surgeons notified the data center when
their patient reached endpoint. Their decision was blindly reviewed by a c
entralized adjudication process. The current analysis asks: (1)Did the surg
eons and the blinded adjudication process agree on the presence of shunt fa
ilure? (2) Do the shunt survival curves change when the surgeons' assessmen
t of outcome is used?
Methods: The two methods of outcome assessment (surgeons' decision and adju
dication process) were compared with a kappa statistic for the presence of
shunt failure and a log rank statistic for time to shunt failure.
Results: The surgeon and the adjudication process agreed on the presence of
the primary outcome in 313/344 patients in the trial (kappa = 0.81). The 3
1 cases of disagreement were evenly distributed among the three shunts. The
survival curves generated from the surgeons' decision were not significant
ly different from those generated by the adjudication process (log rank = 0
.70, p = 0.37) and did not alter the study conclusions.
Discussion: Observer bias in the assessment of outcome is always a concern
in an unblinded clinical trial such as this one. We did not detect an obser
ver bias of sufficient magnitude to alter the study conclusions.